Mandate

Vinge assisted Altor Fund III in connection with sale of shares in CTEK AB (publ)

Vinge assisted Altor Fund III GP Limited (”Altor”) in connection with the sale of shares in CTEK AB (publ) (”CTEK”) through an accelerated bookbuilding process. Altor sold shares to a value of SEK 621 million and holds approximately 10 per cent of the shares in CTEK after the sale.

Vinge’s team consisted of David Andersson and Isabell Anstrin.

 

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024